Dallah Healthcare Company (4004.SR) SAU
Currency In SAR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.69B |
| Enterprise Value | 16.42B |
| P/E Ratio | 22.99 |
| PEG Ratio | -1.35 |
| Price/Sales Ratio | 2.37 |
| Price/Book Ratio | 2.46 |
| Enterprise/Revenue | 3.34 |
| Enterprise/EBITDA | 18.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 4.07B |
| Revenue/Share | 42.54 |
| Gross Profit | 1.42B |
| EBITDA | 783.5M |
| Net Income | 538M |
| Diluted EPS | 5.32 |
Balance Sheet
| Total Cash | 87.85M |
| Total Cash/Share | 0.87 |
| Total Debt | 4.23B |
| Total Debt/Equity | 1.02 |
| Current Ratio | 1.21 |
| Book Value Per Share | 41.23 |
Price History
| 52-Week Change | -22.36 |
| 52-Week High | 157.3 |
| 52-Week Low | 90 |
| Moving Average 50 Days | 107.32 |
| Moving Average 200 Days | 117.4 |
Statistics
| Average Volume | 116,894 |
| Shares Outstanding | 101.2M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.99 |
| Payout Ratio | 0.45 |
| Last Split Factor | 6:5 |
| Last Split Date | August 31, 2026 |
AD
